Health Canada

It provides information on how to report a marketing complaint.

The health and safety of all Canadians is Health Canada's top priority and we are taking urgent measures to protect consumers from illegal, false or misleading advertising of products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19. These practices are deemed non-compliant with...

COVID-19 is a global public health challenge that has changed the daily lives of people around the world. During these difficult times, it is critical that Canadians be able to obtain credible information and access services to support their mental health and wellbeing.

In response to the increasing demand for hand sanitizers in Canada during the current COVID-19 pandemic, Health Canada has implemented an interim expedited licensing approach to help businesses obtain the required authorizations to produce and distribute hand sanitizer.

Information about food safety during the coronavirus disease (COVID-19) pandemic and how to keep you and your family safe.

There are diagnostics tests, masks and a thermal camera now available through an Interim Order that allows expedited access to COVID-19-related medical devices. Health Canada has also expedited authorization for medical device establishment licence (MDEL) applications related to products such as...

Currently, the treatment of COVID-19 includes supportive care and treatment of any secondary infections, such as pneumonia. There are no drugs or vaccines approved, but there are now 18 clinical trials authorized in Canada with diagnostic equipment, supportive care and/or treatments for COVID-19.

This list contains non-diagnostic devices of all classes - Classes I - IV - that are specifically authorized for use against COVID-19. These devices are authorized under the Interim order respecting the importation and sale of medical devices for use in relation to COVID-19. However, this list...

Presents a list of medical devices for use against COVID-19 applications submitted for authorization according to the Interim Order. This application list is updated daily Monday to Friday

Presents a list of medical devices for use against COVID-19 applications submitted for authorization according to the Interim Order. This application list is updated daily Monday to Friday

Guidance documents for management of drugs for clinical trials involving human subjects. The sponsor must ensure that the clinical trial is conducted in accordance with the requirements of the protocol, which has been authorized by Health Canada and approved by REB(s).

COVID-19 is a new disease. A vaccine or therapy to treat or prevent this disease has not yet been developed. However, the COVID-19 pandemic has resulted in a global review of therapies that may be used to treat or prevent the disease. Canada is speeding up the importation and sale of medical...

To assist with Canada’s response to COVID-19, the Honourable Patty Hajdu, Minister of Health, announced that she has signed an Interim Order to allow expedited access to COVID-19-related medical devices for use by healthcare providers, including diagnostic test kits.

The Minister of Health, pursuant to subsection 30.1‍(1)Footnote(i) of the Food and Drugs Act Footnote(ii), makes the annexed Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19.

Overview of the Health Portfolio, issues/priorities for the first 100 days and a pocket book with Health Portfolio highlights.

COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the...

"Health Canada appreciates the critical role health professionals in Canada play in identifying, reporting and managing potential cases of COVID-19 and recognizes the pressures a surge in people requiring medical care can cause on facilities. In light of the current situation, Health Canada is...

In light of the COVID-19 outbreak, Health Canada is clarifying expectations for manufacturers, importers and market authorization holders (MAHs) regarding requirement to report adverse reactions (ARs) and medical device problems (MDPs) during a pandemic.

Deputy Minister Briefing Material – September 2019 - Overview of Health Canada as well as information on Governance and Operations.

Health Canada’s report on fees for fiscal year 2018 to 2019 is the second annual report under the Service Fees Act. This year’s report provides more detail on each fee, such as the type and rate of adjustment, the service standard and the performance result. This information provides additional...